[1] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2019年版). 肝脏,2019, 24:1335-1356.
[2] Liu J, Liang W, Jing W, et al. Countdown to 2030: eliminating hepatitis?B disease, China. Bull World Health Organ, 2019, 97: 230-238.
[3] Guo H, Xu C, Zhou T, et al. Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation. PLoS One, 2012, 7: e43270.
[4] Wang J, Huang H, Liu Y, et al. HBV Genome and Life Cycle. Adv Exp Med Biol, 2020, 1179: 17-37.
[5] Allweiss L, Volz T, Giersch K, et al. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Gut, 2018, 67: 542-552.
[6] Liu Y, Liu H, Hu Z, et al. Hepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of Irreversible DNA Chain Termination. Hepatology, 2020, 71: 463-476.
[7] Huang Q, Zhou B, Cai D, et al. Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients. Hepatology, 2021,73(1):41-52.
[8] Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology, 2013, 57: 985-994.
[9] Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife, 2012, 1: e00049.
[10] Rabe B, Delaleau M, Bischof A, et al. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog, 2009, 5: e1000563.
[11] Xia Y, Guo H. Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential. Antiviral Res, 2020, 180: 104824.
[12] Qi Y, Gao Z, Xu G, et al. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus. PLoS Pathog, 2016, 12: e1005893.
[13] Wei L, Ploss A. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation. Nat Microbiol, 2020, 5: 715-726.
[14] Zhao Q, Guo JT. Have the Starting Lineup of Five for Hepatitis B Virus Covalently Closed Circular DNA Synthesis Been Identified?. Hepatology, 2020, 72: 1142-1144.
[15] Luo J, Luckenbaugh L, Hu H, et al. Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation. mBio.?2020,11(1):e03423-19.
[16] Junker-Niepmann M, Bartenschlager R, Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. Embo J, 1990, 9: 3389-3396.
[17] Haines KM, Loeb DD. The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J Mol Biol, 2007, 370: 471-480.
[18] Lien JM, Aldrich CE, Mason WS. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol, 1986, 57: 229-236.
[19] Habig JW, Loeb DD. Sequence identity of the direct repeats, DR1 and DR2, contributes to the discrimination between primer translocation and in situ priming during replication of the duck hepatitis B virus. J Mol Biol, 2006, 364: 32-43.
[20] Bock CT, Schwinn S, Locarnini S, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol, 2001, 307: 183-196.
[21] Qiao Y, Han X, Guan G, et al. TGF-β triggers HBV cccDNA degradation through AID-dependent deamination. FEBS Lett, 2016, 590: 419-427.
[22] Mohd-Ismail NK, Lim Z, Gunaratne J, et al. Mapping the Interactions of HBV cccDNA with Host Factors. Int J Mol Sci, 2019, 20:4276.
[23] Shen C, Feng X, Mao T, et al. Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11. Emerg Microbes Infect, 2020, 9: 2455-2464.
[24] Guo H, Jiang D, Zhou T, et al. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol, 2007, 81: 12472-12484.
[25] Dandri M. Epigenetic modulation in chronic hepatitis B virus infection. Semin Immunopathol, 2020, 42: 173-185.
[26] Zhang Y, Li C, Zhang Y, et al. Comparative analysis of CpG islands among HBV genotypes. PLoS One, 2013, 8: e56711.
[27] Vivekanandan P, Thomas D, Torbenson M. Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat, 2008, 15: 103-107.
[28] Vivekanandan P, Daniel HD, Kannangai R, et al. Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol, 2010, 84: 4321-4329.
[29] Ren JH, Hu JL, Cheng ST, et al. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases. Hepatology, 2018, 68: 1260-1276.
[30] Yang B, Li B, Jia L, et al. 3D landscape of Hepatitis B virus interactions with human chromatins. Cell Discov, 2020, 6: 95.
[31] Dong C, Qu L, Wang H, et al. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication. Antiviral Res, 2015, 118: 110-117.
[32] Cai D, Mills C, Yu W, et al. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation. Antimicrob Agents Chemother, 2012, 56: 4277-4288. |
